glp-1 intestine and Gut Health: Addressing Metabolic Dysfunction for Physicians Intestinal HIF-2α Regulates GLP-1 Secretion

nature.com/articles/s43016-021-00381-y.epdf?sharing_token=rXE-EUQhF_ewQyjads3RTtRgN0jAjWel9jnR3ZoTv0PPFX4_UgkV63y9Env4jkUDyrBA_9kG-Lxz6QgkvVdmMKBlJ7k8y7v30cRFyRNAydxlY5YNATNy6EWMVYTeCU4NpFXpSNA6XuOIH9vjNYTOYkuaOA7QRr1Af7rKzgFOzDs%3D #8

Abstract Diabetic neuropathy (DN) is a common and debilitating complication of diabetes mellitus, often presenting with chronic pain and sensory or motor deficits

However, some patterns stood out

Table 4 Overview of Clinical Trials Investigating Therapies for Diabetic Neuropathy - Including Both Microneedle-Based and Conventional Approaches that are being investigated to provide disease modification and symptomatic relief, but do not involve microneedles

This is where new medical advancements can make a real difference

Fiber matters too, as it may help ease common GLP-1 side effects like constipation or diarrhea